| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $82.5M | — | -2.5% |
| Cost of Revenue | $19.4M | — | +13.8% |
| Gross Profit | $63.0M | — | -6.6% |
| R&D Expense | $14.5M | — | -19.7% |
| SG&A Expense | $23.8M | — | +11.1% |
| Operating Income | -$10.8M | — | -286.4% |
| Pre-tax Income | -$9.4M | — | -2036.4% |
| Income Tax | $969K | — | +1445.8% |
| Net Income | -$10.3M | — | -1959.8% |
| EPS (Basic) | -$0.43 | — | -2250.0% |
| EPS (Diluted) | -$0.43 | — | -2250.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $164.6M | -11.8% | -44.6% |
| Accounts Receivable | $183.1M | -12.3% | -11.2% |
| Current Assets | $361.0M | -11.5% | -31.6% |
| Total Assets | $479.9M | -8.7% | -24.9% |
| Current Liabilities | $200.9M | -3.3% | +2.2% |
| Total Liabilities | $230.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $30.4M | — | +52.9% |
| Capital Expenditures | $3.1M | — | +62.0% |
| Investing Cash Flow | -$7.1M | — | -42.1% |
| Financing Cash Flow | -$45.3M | — | +32.4% |
| Free Cash Flow | $27.3M | — | +52.0% |
| -3.0% |
| Stockholders' Equity | $249.0M | -13.4% | -38.0% |